Meanwhile, some reports have verified that HDAC inhibition modulates the PTEN/PI3K/AKT axis to combat TBI and neurological diseases characterized by white matter as well as gray matter destruction, such as stroke and neurodegenerative disorders (Liu et al., 2012; Wang et al., 2015). This evidence concerns the gene AKT1 and nervous system disorder.